Author:
Saadoun David,Bura-Riviere Alessandra,Comarmond Chloé,Lambert Marc,Redheuil Alban,Mirault Tristan,Achouh Paul,Aeschlimann Florence,Alsac Jean-Marc,Arnaud Laurent,Benhamou Ygal,Bienvenu Boris,Bodiguel Eric,Boyer Olivia,Chiche Laurent,Constans Joel,Darbon Raphael,Guibaudet Sandrine,Lamarche Philippe,Ferrand Séverin,Espitia Olivier,Franchi Stephanie,Gaudric Julien,Giordana Pascal,Hachulla Eric,Hatron Pierre-Yves,Hot Arnaud,Kone-Paut Isabelle,Maillard Hélène,Mekinian Arsène,Quartier Pierre,Quemeneur Thomas,Soussan Mickael,Sapoval Marc,Schmidt Jean,Soulat Gilles,
Abstract
AbstractThe aim of this National Diagnostic and Care Protocol (PNDS) is to explain to the professionals involved the current optimal diagnosis and therapeutic management and care approach for a patient with Takayasu’s arteritis. Its purpose is to optimize and harmonize the management and follow-up of this rare disease throughout the country. It also identifies pharmaceutical specialties used in an indication not provided for in the Marketing Authorization, as well as the specialties, products or services necessary for the care of patients but not usually paid for or reimbursed.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Genetics(clinical),General Medicine